VERA

Vera Therapeutics
VERA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.42B
EV
$838.45M
Shares Outstanding
65.52M
Beta
1.28

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$64.23
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vera Therapeutics, Inc.

gainify
VERA

Vera Therapeutics, Inc.

VERA

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous inject...

Sector

Healthcare

Industry

Biotechnology

CEO

Fordyce, Marshall

Employees

112

Website

veratx.com

IPO Date

2021-05-14

Headquarters

8000 Marina Boulevard, Suite 120, Brisbane, California, 94005, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved